Moneyta · stock research · no sign-up needed
ZBH
FollowFigures below come straight from SEC filings: every number is the company's own, on the record.
Revenue (Q2 FY2026)
$2.2B
+14.0% y/y
Net income (Q2 FY2026)
$198M
as filed with the SEC
Institutions holding
915
-7 last quarter
Overview · ZIMMER BIOMET HOLDINGS, INC.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and t…
Management team
- Ms. Angela Main · Senior VP, Global Chief Compliance Officer & Associate General Counsel of Asia PacificFind on LinkedIn
- Ms. Keri P. Mattox · SVP and Chief Communications & Administration OfficerFind on LinkedIn
- Mr. Zeeshan Tariq · Senior VP & Chief Information OfficerFind on LinkedIn
- Mr. Sang Yi · President of Asia PacificFind on LinkedIn
Start free to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
What history says when its signals fire
Every signal Moneyta surfaces carries its full base-rate history: how often it beat the index, and how often it didn't. See the evidence
The desk's Snapshot
3 of 15 open to everyone · members see allRead the full desk report on ZBH
Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.
Free plan, no credit card required. Silver opens the full report, $19.99 a month. AI-written · every claim cites a source · Insight, not advice.
The full desk report
Seven AI analysts read the filings and argue both sides. What survives, with every claim cited, for members.
Who holds it, who's buying Gold
Full holder table, quarter-over-quarter flows, insider transactions, and the conviction screen.
Largest holder
Net flow last quarter
Insider buys, 90d
Further reading
Source: SEC EDGAR (XBRL company facts, form 13F-HR). Educational analysis of published data: insight, not advice.